ISPEExecution MethodologyGuidance
ISPE Baseline Guide Vol. 5 (2019)

Commissioning and Qualification (Second Edition)

The industry guide that operationalises ASTM E2500’s risk- and science-based approach into an integrated commissioning and qualification lifecycle. It introduces the System Risk Assessment, Critical Aspects, and Critical Design Elements (CDEs), and folds commissioning and qualification into a single verification effort.

LAST REVISED
July 2019
PRODUCT AREAS
SterileSolid DoseBiotechApi
SCOPE & APPLICABILITY

Commissioning and qualification of facilities, utilities, and equipment used in regulated manufacturing, across the design, verification, and acceptance lifecycle.

KEY REQUIREMENTS
  • 01System Risk Assessment to focus qualification on Critical Aspects
  • 02Identification of Critical Design Elements during design review
  • 03Integrated commissioning and qualification to avoid duplicate testing
  • 04SME-led verification with documented quality-unit approval
IMPLEMENTATION TIPS
Run the design review early to capture CDEs before construction locks them in
Reuse commissioning and FAT/SAT evidence in qualification where risk allows — document the justification
Keep the requirements → risk → verification thread traceable per system
REVISION NOTES

Second Edition (2019) replaced the 2001 first edition, aligning C&Q to ASTM E2500 and ICH Q8/Q9/Q10. It is the primary implementation reference for risk-based C&Q.

ISPE Baseline Guide Vol. 5 (2019): frequently asked questions

Quick answers to common questions about ISPE Baseline Guide Vol. 5 (2019).

What is ISPE Baseline Guide Vol. 5 (2019)?

ISPE Baseline Guide Vol. 5 (2019) — Commissioning and Qualification (Second Edition) — is a guidance issued by the International Society for Pharmaceutical Engineering. The industry guide that operationalises ASTM E2500’s risk- and science-based approach into an integrated commissioning and qualification lifecycle. It introduces the System Risk Assessment, Critical Aspects, and Critical Design Elements (CDEs), and folds commissioning and qualification into a single verification effort.

Who does ISPE Baseline Guide Vol. 5 (2019) apply to?

Commissioning and qualification of facilities, utilities, and equipment used in regulated manufacturing, across the design, verification, and acceptance lifecycle.

What are the key requirements of ISPE Baseline Guide Vol. 5 (2019)?

ISPE Baseline Guide Vol. 5 (2019) requires, among other things: System Risk Assessment to focus qualification on Critical Aspects; Identification of Critical Design Elements during design review; Integrated commissioning and qualification to avoid duplicate testing; SME-led verification with documented quality-unit approval.

When was ISPE Baseline Guide Vol. 5 (2019) last updated?

The current version of ISPE Baseline Guide Vol. 5 (2019) dates from July 2019. Second Edition (2019) replaced the 2001 first edition, aligning C&Q to ASTM E2500 and ICH Q8/Q9/Q10. It is the primary implementation reference for risk-based C&Q.

RELATED STANDARDS
RELATED FDA RECALLS
where Validation & Qualification control fails
See all Validation & Qualification recalls →

Live openFDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.

THIS STANDARD IN PRACTICE

Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.

Weekly Briefing

Track the standards that move

When ISPE Baseline Guide Vol. 5 (2019) — or any GxP requirement — is revised, recalled against, or clarified by new guidance, the Weekly GxP Briefing surfaces it. Free, one email a week.

Read a past issue →